Hasil Pencarian - Anouk Déruaz‐Luyet
- Menampilkan 1 - 17 hasil dari 17
-
1
-
2
Potential paraneoplastic syndromes and selected autoimmune conditions in patients with non-small cell lung cancer and small cell lung cancer: A population-based cohort study. oleh Montserrat Miret, Erzsébet Horváth-Puhó, Anouk Déruaz-Luyet, Henrik Toft Sørensen, Vera Ehrenstein
Diterbitkan 2017-01-01
Artikel -
3
-
4
Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diabetes oleh Gregory A. Nichols, Anouk Derúaz-Luyet, Kimberly G. Brodovicz, Teresa M. Kimes, A. Gabriela Rosales, Sibylle J. Hauske
Diterbitkan 2020-05-01
Artikel -
5
Correction to: Kidney disease progression and all-cause mortality across estimated glomerular filtration rate and albuminuria categories among patients with vs. without type 2 diab... oleh Gregory A. Nichols, Anouk Déruaz-Luyet, Kimberly G. Brodovicz, Teresa M. Kimes, A. Gabriela Rosales, Sibylle J. Hauske
Diterbitkan 2020-05-01
Artikel -
6
Family practitioners' top medical priorities when managing patients with multimorbidity: a cross-sectional study oleh Lilli Herzig, Yolanda Mueller, Dagmar M Haller, Andreas Zeller, Stefan Neuner-Jehle, Anouk Déruaz-Luyet, Christine Cohidon, Sven Streit, Bernard Burnand, Jean-Christophe Zuchuat
Diterbitkan 2019-01-01
Artikel -
7
Determinants associated with deprivation in multimorbid patients in primary care-A cross-sectional study in Switzerland. oleh Silja Leiser, Anouk Déruaz-Luyet, A Alexandra N'Goran, Jérôme Pasquier, Sven Streit, Stefan Neuner-Jehle, Andreas Zeller, Dagmar M Haller, Lilli Herzig, Patrick Bodenmann
Diterbitkan 2017-01-01
Artikel -
8
The EMPagliflozin compaRative effectIveness and SafEty (EMPRISE) study programme: Design and exposure accrual for an evaluation of empagliflozin in routine clinical care oleh Elisabetta Patorno, Mehdi Najafzadeh, Ajinkya Pawar, Jessica M. Franklin, Anouk Déruaz‐Luyet, Kimberly G. Brodovicz, Adrian J. Santiago Ortiz, Lily G. Bessette, Martin Kulldorff, Sebastian Schneeweiss
Diterbitkan 2020-01-01
Artikel -
9
Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study oleh Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno
Diterbitkan 2024-03-01
Artikel -
10
Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study oleh Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno
Diterbitkan 2024-02-01
Artikel -
11
Varied treatment patterns among patients with palmoplantar pustulosis: A claims-based cohort study using data from 2 large US databases oleh Jashin J. Wu, MD, Ran Gao, MS, Rhonda L. Bohn, ScD, Anouk Déruaz-Luyet, PhD, Stephani Gray, MPH, Frank Baehner, MD, Steven R. Feldman, PhD
Diterbitkan 2024-06-01
Artikel -
12
Poor adherence to and persistence with biologics in generalized pustular psoriasis: A claim-based study using real-world data from two large US databasesCapsule Summary oleh Steven R. Feldman, MD, Rhonda L. Bohn, ScD, Ran Gao, MS, Stephani Gray, MPH, Sabrina E. Walton, MSPH, Anouk Déruaz-Luyet, PhD, MPH, Jashin J. Wu, MD
Diterbitkan 2024-06-01
Artikel -
13
Varied treatment pathways with no defined treatment sequencing in patients with generalized pustular psoriasis: A claims-based study oleh Steven R. Feldman, MD, PhD, Ran Gao, MS, Rhonda L. Bohn, ScD, Stephani Gray, MPH, Sabrina E. Walton, MSPH, Anouk Déruaz-Luyet, PhD, MPH, Jashin J. Wu, MD
Diterbitkan 2024-06-01
Artikel -
14
Multimorbidity: can general practitioners identify the health conditions most important to their patients? Results from a national cross-sectional study in Switzerland oleh Anouk Déruaz-Luyet, Alexandra A. N’Goran, Jérôme Pasquier, Bernard Burnand, Patrick Bodenmann, Stefan Zechmann, Stefan Neuner-Jehle, Nicolas Senn, Daniel Widmer, Sven Streit, Andreas Zeller, Dagmar M. Haller, Lilli Herzig
Diterbitkan 2018-05-01
Artikel -
15
Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study oleh Dae Jung Kim, Wayne H‐H Sheu, Wook‐Jin Chung, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Elise Chia‐Hui Tan, Koichi Node, Atsutaka Yasui, Weiyu Lei, Sunwoo Lee, Laura Saarelainen, Anouk Deruaz‐Luyet, Moe H Kyaw, Yutaka Seino, EMPRISE East Asia Study Group
Diterbitkan 2023-03-01
Artikel -
16
Healthcare resource utilization in patients treated with empagliflozin in East Asia oleh Wayne H‐H Sheu, Yutaka Seino, Elise Chia‐Hui Tan, Daisuke Yabe, Kyoung Hwa Ha, Masaomi Nangaku, Wook‐Jin Chung, Koichi Node, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Anastasia Ustyugova, Riho Klement, Anouk Deruaz‐Luyet, Moe H Kyaw, Dae Jung Kim, the EMPRISE East Asia study group
Diterbitkan 2022-05-01
Artikel -
17
Cardiovascular and renal effectiveness of empagliflozin in routine care in East Asia: Results from the EMPRISE East Asia study oleh Yutaka Seino, Dae Jung Kim, Daisuke Yabe, Elise Chia‐Hui Tan, Wook‐Jin Chung, Kyoung Hwa Ha, Masaomi Nangaku, Koichi Node, Riho Klement, Atsutaka Yasui, Wei‐Yu Lei, Sunwoo Lee, Moe H. Kyaw, Anouk Deruaz‐Luyet, Kimberly G. Brodovicz, Wayne H.‐H. Sheu, the EMPRISE East Asia study group
Diterbitkan 2021-01-01
Artikel